HIMS insider transactions

Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax

Chief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)

Chief Operating Officer Chi Michael covered exercise/tax liability with 47,699 shares, sold $441,850 worth of shares (14,027 units at $31.50) as part of a pre-agreed trading plan and converted options into 86,264 shares, increasing direct ownership by 6% to 432,124 units (SEC Form 4) (withholding obligation)

Chief Policy Officer Autor Deborah M. covered exercise/tax liability with 15,396 shares and converted options into 32,919 shares, increasing direct ownership by 56% to 48,961 units (SEC Form 4)

PAO Becklund Irene converted options into 15,971 shares, covered exercise/tax liability with 5,870 shares and sold $370,518 worth of shares (12,063 units at $30.72) as part of a pre-agreed trading plan, decreasing direct ownership by 22% to 6,790 units (SEC Form 4) (for tax liability)

Chief Legal Officer Boughton Soleil converted options into 42,261 shares and covered exercise/tax liability with 23,315 shares, increasing direct ownership by 6% to 318,314 units (SEC Form 4) to cover taxes

Chief Executive Officer Dudum Andrew covered exercise/tax liability with 85,632 shares and converted options into 154,991 shares, increasing direct ownership by 8% to 957,043 units (SEC Form 4) (withholding tax)

CTO Elshenawy Mohamed converted options into 282,597 shares, covered exercise/tax liability with 151,534 shares and sold $946,260 worth of shares (30,040 units at $31.50) as part of a pre-agreed trading plan (SEC Form 4) (tax withholding)

Director Wells David B converted options into 4,613 shares, increasing direct ownership by 2% to 229,030 units (SEC Form 4)

Director Perez Garcia Andrea G converted options into 3,656 shares, increasing direct ownership by 5% to 83,822 units (SEC Form 4)

Director Schultz Kare converted options into 3,656 shares, increasing direct ownership by 23% to 19,397 units (SEC Form 4)

Chief Medical Officer Carroll Patrick Harrison converted options into 4,091 shares, increasing direct ownership by 2% to 187,971 units (SEC Form 4)

Chief Policy Officer Autor Deborah M. converted options into 3,656 shares, increasing direct ownership by 13% to 31,438 units (SEC Form 4)

SEC Form 3 filed by new insider Amoo-Gottfried Kofi Owusu

Director Payne Christopher D converted options into 14,343 shares, increasing direct ownership by 72% to 34,318 units (SEC Form 4)

Director Pendarvis Christiane converted options into 3,656 shares, increasing direct ownership by 7% to 55,430 units (SEC Form 4)

Director Manuel Anja converted options into 13,696 shares, increasing direct ownership by 55% to 38,671 units (SEC Form 4)

Director Cosgrove Delos M. converted options into 3,656 shares, increasing direct ownership by 6% to 67,995 units (SEC Form 4)

Director Wells David B bought $1,172,974 worth of shares (48,400 units at $24.23), increasing direct ownership by 27% to 224,417 units (SEC Form 4)

SEC Form 4 filed by Chief Medical Officer Carroll Patrick Harrison

SEC Form 4 filed by Director Wells David B

SEC Form 4 filed by Director Payne Christopher D

Chief Financial Officer Okupe Oluyemi exercised 7,950 shares at a strike of $5.01 and sold $187,916 worth of shares (7,950 units at $23.64) as part of a pre-agreed trading plan (SEC Form 4)

SEC Form 4 filed by Okupe Oluyemi

SEC Form 4 filed by Boughton Soleil

SEC Form 4 filed by Okupe Oluyemi

SEC Form 4 filed by Dudum Andrew

SEC Form 4 filed by Okupe Oluyemi

SEC Form 4 filed by Okupe Oluyemi

SEC Form 4 filed by Becklund Irene

SEC Form 4 filed by Chi Michael

SEC Form 4 filed by Boughton Soleil

Chief Operating Officer Chi Michael converted options into 72,108 shares and covered exercise/tax liability with 237,756 shares, decreasing direct ownership by 25% to 504,571 units (SEC Form 4)

Chief Medical Officer Carroll Patrick Harrison converted options into 16,522 shares and covered exercise/tax liability with 4,022 shares, increasing direct ownership by 7% to 182,440 units (SEC Form 4)

Director Pendarvis Christiane converted options into 15,211 shares, increasing direct ownership by 42% to 51,774 units (SEC Form 4)

Chief Policy Officer Autor Deborah M. converted options into 32,919 shares and covered exercise/tax liability with 11,312 shares, increasing direct ownership by 350% to 27,782 units (SEC Form 4)

PAO Becklund Irene converted options into 17,987 shares and covered exercise/tax liability with 5,832 shares, increasing direct ownership by 572% to 14,281 units (SEC Form 4)

Chief Executive Officer Dudum Andrew covered exercise/tax liability with 526,486 shares and converted options into 164,369 shares, decreasing direct ownership by 22% to 1,310,617 units (SEC Form 4)

Chief Legal Officer Boughton Soleil covered exercise/tax liability with 168,750 shares and converted options into 41,421 shares, decreasing direct ownership by 29% to 313,643 units (SEC Form 4)

Chief Financial Officer Okupe Oluyemi converted options into 105,200 shares and covered exercise/tax liability with 283,990 shares, decreasing direct ownership by 36% to 323,517 units (SEC Form 4)

SEC Form 4 filed by PAO Becklund Irene

SEC Form 4 filed by Chief Policy Officer Autor Deborah M.

SEC Form 4 filed by Chief Operating Officer Chi Michael

SEC Form 4 filed by Chief Medical Officer Carroll Patrick Harrison

SEC Form 4 filed by Chief Legal Officer Boughton Soleil

SEC Form 4 filed by CTO Elshenawy Mohamed

SEC Form 4 filed by Chief Executive Officer Dudum Andrew

SEC Form 4 filed by Chief Financial Officer Okupe Oluyemi

Chief Legal Officer Boughton Soleil sold $70,742 worth of shares (4,651 units at $15.21), decreasing direct ownership by 1% to 440,972 units (SEC Form 4)

Chief Legal Officer Boughton Soleil was granted 273,794 shares, increasing direct ownership by 159% to 445,623 units (SEC Form 4)

Chief Financial Officer Okupe Oluyemi was granted 410,690 shares, increasing direct ownership by 448% to 502,307 units (SEC Form 4)

Chief Operating Officer Chi Michael was granted 365,058 shares, increasing direct ownership by 120% to 670,219 units (SEC Form 4)

Chief Executive Officer Dudum Andrew was granted 794,002 shares, increasing direct ownership by 90% to 1,672,734 units (SEC Form 4)

Chief Financial Officer Okupe Oluyemi exercised 5,262 shares at a strike of $5.01 and sold $139,108 worth of shares (5,262 units at $26.44) (SEC Form 4)

Chief Financial Officer Okupe Oluyemi exercised 9,067 shares at a strike of $6.27 and sold $275,114 worth of shares (9,067 units at $30.34) (SEC Form 4)

Chief Financial Officer Okupe Oluyemi exercised 5,986 shares at a strike of $9.16 and sold $306,453 worth of shares (9,070 units at $33.79), decreasing direct ownership by 3% to 91,617 units (SEC Form 4)

Chief Financial Officer Okupe Oluyemi sold $824,710 worth of shares (23,090 units at $35.72), decreasing direct ownership by 20% to 94,333 units (SEC Form 4)

Chief Medical Officer Carroll Patrick Harrison sold $367,871 worth of shares (10,021 units at $36.71), decreasing direct ownership by 6% to 169,940 units (SEC Form 4)

Chief Policy Officer Autor Deborah M. sold $258,952 worth of shares (7,054 units at $36.71), decreasing direct ownership by 53% to 6,175 units (SEC Form 4)

Chief Operating Officer Chi Michael sold $504,762 worth of shares (13,750 units at $36.71), decreasing direct ownership by 4% to 305,161 units (SEC Form 4)